CMS' final drug price rule doesn't include price concessions

Modern Healthcare: The Trump administration on Thursday released a final rule aimed at boosting transparency of drug costs on Medicare Part D, but it does not include a proposal to pass on price concessions negotiated by the pharmacy to patients.

While the agency had wanted to implement the new policy in 2020, the CMS said in a release that it is not implementing it after receiving more than 4,000 comments.

Read article

i360Gov Newsletters

The most significant government policy, business, and technology news and analysis delivered to your inbox.

Subscribe Now

Trending